NFKB1 and cancer: Additionally, previous evidence has illustrated NF-κB activation and its role in driving breast cancer development and progression via its role in cancer stem cells (CSC), epithelial to mesenchymal transition (EMT) and resistance to endocrine and chemotherapies.